Silo Pharma, Inc.
SILO
$2.15
-$0.13-5.70%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -4.47M | -4.84M | -4.23M | -5.08M | -4.90M |
| Total Depreciation and Amortization | 11.60K | 11.20K | 11.40K | 11.60K | 11.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.65M | 1.62M | 739.00K | 581.80K | 13.60K |
| Change in Net Operating Assets | -528.90K | -635.90K | -1.18M | -315.00K | -319.60K |
| Cash from Operations | -3.34M | -3.84M | -4.66M | -4.80M | -5.19M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -455.70K | -251.00K | 644.00K | 1.13M | 1.18M |
| Cash from Investing | -455.70K | -251.00K | 644.00K | 1.13M | 1.18M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.77M | 4.86M | 4.86M | 2.73M | 3.84M |
| Repurchase of Common Stock | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -27.00K | -- | -- | -- | -- |
| Cash from Financing | 2.74M | 4.86M | 4.86M | 2.73M | 3.84M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.06M | 765.70K | 843.00K | -943.20K | -172.60K |